For the Inventor, By the Inventor

Enter assignee name

Leuven, Belgium

K.u. Leuven Research & Development

USPTO Granted Patents = 84

CIPO Patents = 16

EPO Patents = 39

Forward Citations = 1,498

Loading Chart...

Loading Chart...

234 inventors (with patents filed for the assignee):

David A Oare (10 out of 32 patents)

Steven S Bondy (9 out of 20 patents)

Erik De Clercq (9 out of 13 patents)

4. Piet Herdewijn (8 out of 19 patents)

5. Jan Balzarini (7 out of 33 patents)

6. Johan Neyts (6 out of 25 patents)

7. Vahid Zia (6 out of 20 patents)

8. Ignace H Verpoest (6 out of 6 patents)

9. Johan Adriaan Martens (5 out of 36 patents)

10. Tongfei Wu (5 out of 27 patents)

11. Christophe Pannecouque (5 out of 7 patents)

12. Roger Bouillon (5 out of 9 patents)

13. Christopher McGuigan (4 out of 38 patents)

14. Winston C Tse (4 out of 39 patents)

15. Eric Dowdy (4 out of 17 patents)

Core Competencies:

Antiviral Compounds

Phosphonate Nucleosides

Nucleotide Analogues

Pyrimidine Nucleoside Derivatives

Viral Inhibitors

Controlled Release Delivery

Robust Interest Point Detector

Azacytosine Derivatives

Integrase Cofactor

Sintered Porous Materials

Antithrombotic Therapy

Crystalline Mesoporous Oxide

84 patents: Sort by Forward Citations

1. 11174497 - Yeast alleles involved in tolerance to high alcohol levels (2021-11-16),

2. 10087209 - Antiviral compounds, a process for their preparation, and their use for treating viral infections (2018-10-02),

3. 9522932 - Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production (2016-12-20),

4. 9427447 - Anti-viral pyrimidine nucleoside derivatives (2016-08-30),

5. 9249177 - Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production (2016-02-02),

6. 9242983 - Viral inhibitors (2016-01-26),

7. 8884011 - Nucleotide analogues as precursor molecules for antivirals (2014-11-11),

8. 8859512 - Anti-viral pyrimidine nucleoside derivatives (2014-10-14),

9. 8809520 - Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production (2014-08-19),

10. 8795806 - Half closed thermoplastic honeycomb, their production process and equipment to produce (2014-08-05),

11. 8790697 - Controlled release delivery system for bio-active agents (2014-07-29),

12. 8779141 - Viral inhibitors (2014-07-15),

13. 8722677 - Viral inhibitors (2014-05-13),

14. 8670619 - Robust interest point detector and descriptor (2014-03-11),

15. 8658616 - Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis C virus (2014-02-25),

K.U. Leuven Research & Development (LRD) is the technology transfer office of KU Leuven, one of Europe's leading research universities. LRD facilitates the transfer of knowledge, expertise, and technologies developed at KU Leuven to industry, society, and partners worldwide. LRD offers support in patenting, licensing, and spin-off creation, fostering collaborations between academia and businesses for innovation and economic growth.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

84 Patents

#7 in Leuven

#61 in Belgium

#8,743 in the World

Leuven, Belgium

K.u. Leuven Research & Development

Forward Citations = 1,498

234 inventors:

David A Oare (10 out of 32 patents)

Steven S Bondy (9 out of 20 patents)

Erik De Clercq (9 out of 13 patents)

4. Piet Herdewijn (8 out of 19 patents)

5. Jan Balzarini (7 out of 33 patents)

Please report any incorrect information to support@idiyas.com

Loading…